Effect of Mavacamten on Echocardiographic Features in Chinese Patients with Obstructive Hypertrophic Cardiomyopathy: Results from the EXPLORER-CN Study by Zhuang Tian, Xiaoyan Li, Liwen Li, Qing Zhang, Jian’an Wang, Yunqi Shi, Daoquan Peng, Ping Yang, Wei Ma, Fang Wang, Wei Jin, Xiang Cheng, Yu-Mao Chen, Yue Zhong, Yu Chen Barrett, Jing Zheng, Shuyang Zhang

Subjects: Get full text

Temporal Patterns of Holter-Detected Arrhythmias in Hypertrophic Cardiomyopathy Patients Treated with Mavacamten by Amro Badr, Kaitlin Roehl, Mustafa Suppah, Humam Abo Abdullah, Reza Arsanjani, Konstantinos C. Siontis, Jeffrey B. Geske, Steve R. Ommen, John R. Giudicessi, Said Alsidawi

Subjects: “…mavacamten…”
Get full text

Hypertrophic Cardiomyopathy with Special Focus on Mavacamten and Its Future in Cardiology by Ewelina Młynarska, Ewa Radzioch, Bartłomiej Dąbek, Klaudia Leszto, Alicja Witkowska, Witold Czarnik, Weronika Jędraszak, Jacek Rysz, Beata Franczyk

Subjects: Get full text

British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of adult patients with obstructive hypertrophic cardiomyopathy receiving myosin-inh... by Clare M. Culshaw, Daniel Augustine, Caroline J. Coats, Ivo Andrade, Keith Pearce, Antonis Pantazis, William Bradlow, Lauren Turvey, William Moody, Lynne Williams, Rachel Bastianen, Jane Draper, David L. Oxborough, Robert M. Cooper

Subjects: “…Mavacamten…”
Get full text

Diagnostic Challenges and Management of Hypertrophic Cardiomyopathy with Left Ventricular Outflow Tract Obstruction in a Patient with Hypertension by Nina Marta Kubikowska, Martyna Świerkowska, Robert Antoniak, Krzysztof Ozierański, Aleksandra Gąsecka

Subjects: Get full text

Editorial: State-of-the-art muscle physiology research: from single molecules and cells to living organisms by Norio Fukuda, Norio Fukuda, Madoka Suzuki, Kotaro Oyama, Kotaro Oyama, Norika Liu, Norika Liu

Subjects: Get full text

Eighteen‐Month Real‐World Experience Using Mavacamten for Treatment of Obstructive Hypertrophic Cardiomyopathy in a Racially Diverse Population by Diego Ramonfaur, Alessio Gasperetti, Victoria E. Blake, Bryana Rivers, Ali A. Kassamali, Edward K. Kasper, Lili A. Barouch, Katherine C. Wu, Jose A. Madrazo, Richard T. Carrick

Subjects: Get full text

Recent Advances in Novel Modulators for Cardiac Myosin Disorders by Hancheng Wang, Mengfei Wang, Bo Han, Qiushi Chen, Qingwei Zhang

Subjects: Get full text

Safety and Efficacy of Mavacamten and Aficamten in Patients With Hypertrophic Cardiomyopathy by Bryton J. Davis, Hailey Volk, Olives Nguyen, Daniel Kamna, Hongya Chen, Roberto Barriales‐Villa, Pablo Garcia‐Pavia, Iacopo Olivotto, Anjali T. Owens, Caroline J. Coats, Theodore P. Abraham, Scott D. Solomon, Martin S. Maron, Ahmad Masri

Subjects: Get full text

<i>MYBPC3</i> D389V Variant Induces Hypercontractility in Cardiac Organoids by Darshini Desai, Taejeong Song, Rohit R. Singh, Akhil Baby, James McNamara, Lisa C. Green, Pooneh Nabavizadeh, Mark Ericksen, Sholeh Bazrafshan, Sankar Natesan, Sakthivel Sadayappan

Subjects: Get full text

The effect of mavacamten on echocardiographic parameters, cardiac function and biomarkers in hypertrophic cardiomyopathy patients, a systematic review and meta-analysis by Zina Otmani, Noura Abdrabou, Hazem Ayman Elsayed, Mazen Negmeldin Aly Yassin, Mohamed Abouzid, Mahmoud Diaa Hindawi, Ayman K. Awad

Subjects: Get full text

Obstructive hypertrophic cardiomyopathy: from genetic insights to a multimodal therapeutic approach with mavacamten, aficamten, and beyond by Khadija Sarwer, Saeeda Lashari, Nida Rafaqat, Maher, Abdul Raheem, Muneeb Ur Rehman, Syed Muhammad Iraj Abbas

Subjects: Get full text

Mavacamten in real‐life practice: Initial experience at a hypertrophic cardiomyopathy centre by Zaid Abood, Muhammad Fuad Jan, Muddasir Ashraf, Stacie Kroboth, Heather Sanders, McKenzie Schweitzer, Amanda Misicka, Emily Ollerman, Arshad Jahangir, Patrycja Galazka, Abdul Jamil Tajik

Subjects: Get full text

Hypertrophic cardiomyopathy occurred after successful surgical correction of supravalvular aortic stenosis: a case report of Williams–Beuren syndrome by Hongxiao Yu, Yang Ruan, Manfang Sun, Taole Li, Zhihua Nie

Subjects: Get full text

An ALPK3 truncation variant causing autosomal dominant hypertrophic cardiomyopathy is partially rescued by mavacamten by Lisa Leinhos, Paul Robinson, Giulia Poloni, Sophie Broadway-Stringer, Julia Beglov, Adam B. Lokman, Gillian Douglas, Sajjad Nuthay, Oveena Fonseka, Manuel Schmid, Evie Singer, Charlotte Hooper, Kate Thomson, Richard D. Bagnall, Jodie Ingles, Christopher Semsarian, Elizabeth Ormondroyd, Christopher N. Toepfer, Benjamin Davies, Charles Redwood, Hugh Watkins, Katja Gehmlich

Subjects: Get full text

Comprehensive Review: Mavacamten and Aficamten in Hypertrophic Cardiomyopathy by Helin Savsin, Tomasz Tokarek

Subjects: “…mavacamten…”
Get full text

Obstructive Hypertrophic Cardiomyopathy and Aortic Stenosis With High Surgical Risk by Omar M. Abdelfattah, MD, Robyn Bryde, MD, Kutaiba Nazif, MD, Matthew W. Martinez, MD

Subjects: Get full text

Advancements in the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Comprehensive Review by Randeep Gill, Arsalan Siddiqui, Brianna Yee, Michael V. DiCaro, Nazanin Houshmand, Tahir Tak

Subjects: Get full text

Integrative Approaches in the Management of Hypertrophic Cardiomyopathy: A Comprehensive Review of Current Therapeutic Modalities by Marco Maria Dicorato, Gaetano Citarelli, Francesco Mangini, Rossella Alemanni, Miriam Albanese, Sebastiano Cicco, Cosimo Angelo Greco, Cinzia Forleo, Paolo Basile, Maria Cristina Carella, Marco Matteo Ciccone, Andrea Igoren Guaricci, Ilaria Dentamaro

Subjects: Get full text

Mavacamten by Matthew W. Martinez, MD, Dewey Seto, BSBA, Michael Cheung, DHSc, Michele Coiro, MBA, Niki Patel, PharmD, Arnaud Bastien, MD, Jeffrey Lockman, PhD, Sonia Afsari, MD, Milind Y. Desai, MD, MBA

Subjects: Get full text